Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

[Progress on the Role of Toll-like Receptors in Candida Albicans Infections].

Role of Toll-like receptors in systemic Candida albicans infections

Toll-like Receptors (tlrs) Expression and Function in Response to Inactivate Hyphae of Fusarium Solani in Immortalized Human Corneal Epithelial Cells

Toll-like receptors in inflammation, infection and cancer

[Progress on Mechanisms for Pathogensto Evade NOD-like Receptor and Toll-like Receptor Signaling Pathways].

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and TGFβ-activated Kinase 1 (TAK1) Play Essential Roles in the C-type Lectin Receptor Signaling in Response to Candida Albicans Infection

GP IIb/IIIa-Mediated Platelet Activation and Its Modulation of the Immune Response of Monocytes Against Candida Albicans.

[Effect of Toll-like Receptors on Helminth Infection].

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

The effect of herbal medicine in innate immunity to Candida albicans

Time Course of Global Gene Expression Alterations in Candida Albicans During Infection of Hela Cells

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

Candida Tropicalis Induces Pro-Inflammatory Cytokine Production, NF-κB and MAPKs Pathways Regulation, and Dectin-1 Activation.

[Innate immune recognition of the pathogenic parasites by toll-like receptors]

Multiple roles and diverse regulation of the Ras/cAMP/protein kinase A pathway in Candida albicans

Toll-like receptor control of the adaptive immune responses

From Molecular Mechanisms to Clinical Applications

Toll-Like Receptors (TLRs) in Health and Disease: An Overview

Candida Auris Induces Phagocytosis, Reactive Oxygen Species Production and Inflammation Through TLR2, TLR4 and Dectin-1 Dependent Signaling in Macrophages

Toll-Like Receptors: Role in Dermatological Disease